Clemastine

DB00283ApprovedInvestigationalSmall moleculeHistamine Antagonists

Clemastine is an antihistamine with sedative and anticholinergic effects used to treat the symptoms of allergic rhinitis. An ethanolamine-derivative, first generation histamine H1 antagonist used in hay fever, rhinitis, allergic skin conditions, and pruritus.

Chemical structure of Clemastine
Mechanism
Curator reviewed
Primary indication
For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation.Curator reviewed · 6 structured indications
Formula / weight
C21H26ClNO · 343.89 g/mol (avg)
First approval
Canada, 1992 · United States, 1992
Code names
HS-592
Brand names
  • Clemsza
  • Wal-hist 12 Hr Relief

Resolves to

Structure
InChIKeyYNNUSGIPVFPVBX-NHCUHLMSSA-NSMILESCN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1
Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1,069Drug interactionsStructured to mechanism, not free text
Sign in
23Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
55Marketed productsAcross 6 countries and 31 labellers
Sign in
3ATC codesIncluding every combination product, plus 18 drug categories
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Clemastine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account